Cargando…

A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings

BACKGROUND: In South Africa and other high prevalence countries, transmission is a significant contributor to rising rates of multidrug resistant tuberculosis (MDR-TB). Thus, there is a need to develop an early detection system for transmission clusters suitable for high burden settings. We have eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Halima M., Kushner, Nicole, Omar, Shaheed V., Dreyer, Andries W., Koornhof, Hendrik, Erasmus, Linda, Gardee, Yasmin, Rukasha, Ivy, Shashkina, Elena, Beylis, Natalie, Kaplan, Gilla, Fallows, Dorothy, Ismail, Nazir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713439/
https://www.ncbi.nlm.nih.gov/pubmed/26752297
http://dx.doi.org/10.1371/journal.pone.0146106
_version_ 1782410177391099904
author Said, Halima M.
Kushner, Nicole
Omar, Shaheed V.
Dreyer, Andries W.
Koornhof, Hendrik
Erasmus, Linda
Gardee, Yasmin
Rukasha, Ivy
Shashkina, Elena
Beylis, Natalie
Kaplan, Gilla
Fallows, Dorothy
Ismail, Nazir A.
author_facet Said, Halima M.
Kushner, Nicole
Omar, Shaheed V.
Dreyer, Andries W.
Koornhof, Hendrik
Erasmus, Linda
Gardee, Yasmin
Rukasha, Ivy
Shashkina, Elena
Beylis, Natalie
Kaplan, Gilla
Fallows, Dorothy
Ismail, Nazir A.
author_sort Said, Halima M.
collection PubMed
description BACKGROUND: In South Africa and other high prevalence countries, transmission is a significant contributor to rising rates of multidrug resistant tuberculosis (MDR-TB). Thus, there is a need to develop an early detection system for transmission clusters suitable for high burden settings. We have evaluated the discriminatory power and clustering concordance of a novel and simple genotyping approach, combining spoligotyping with pncA sequencing (SpoNC), against two well-established methods: IS6110-RFLP and 24-loci MIRU-VNTR. METHODS: A total of 216 MDR-TB isolates collected from January to June 2010 from the NHLS Central TB referral laboratory in Braamfontein, Johannesburg, representing a diversity of strains from South Africa, were included. The isolates were submitted for genotyping, pncA sequencing and analysis to the Centre for Tuberculosis in South Africa and the Public Health Research Institute Tuberculosis Center at Rutgers University in the United States. Clustering rates, Hunter-Gaston Discriminatory Indexes (HGI) and Wallace coefficients were compared between the methods. RESULTS: Overall clustering rates were high by both IS6110-RFLP (52.8%) and MIRU-VNTR (45.8%), indicative of on-going transmission. Both 24-loci MIRU-VNTR and IS6110-RFLP had similar HGI (0.972 and 0.973, respectively), with close numbers of unique profiles (87 vs. 70), clustered isolates (129 vs. 146), and cluster sizes (2 to 26 vs. 2 to 25 isolates). Spoligotyping alone was the least discriminatory (80.1% clustering, HGI 0.903), with 28 unique types. However, the discriminatory power of spoligotyping was improved when combined with pncA sequencing using the SpoNC approach (61.8% clustering, HGI 0.958). A high proportion of MDR-TB isolates had mutations in pncA (68%, n = 145), and pncA mutations were significantly associated with clustering (p = 0.007 and p = 0.0013 by 24-loci MIRU-VNTR and IS6110-RFLP, respectively), suggesting high rates of resistance to pyrazinamide among all MDR-TB cases and particularly among clustered cases. CONCLUSION: We conclude that SpoNC provides good discrimination for MDR-TB surveillance and early identification of outbreaks in South Africa, with 24-loci MIRU-VNTR applied for pncA wild-type strains as needed.
format Online
Article
Text
id pubmed-4713439
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47134392016-01-26 A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings Said, Halima M. Kushner, Nicole Omar, Shaheed V. Dreyer, Andries W. Koornhof, Hendrik Erasmus, Linda Gardee, Yasmin Rukasha, Ivy Shashkina, Elena Beylis, Natalie Kaplan, Gilla Fallows, Dorothy Ismail, Nazir A. PLoS One Research Article BACKGROUND: In South Africa and other high prevalence countries, transmission is a significant contributor to rising rates of multidrug resistant tuberculosis (MDR-TB). Thus, there is a need to develop an early detection system for transmission clusters suitable for high burden settings. We have evaluated the discriminatory power and clustering concordance of a novel and simple genotyping approach, combining spoligotyping with pncA sequencing (SpoNC), against two well-established methods: IS6110-RFLP and 24-loci MIRU-VNTR. METHODS: A total of 216 MDR-TB isolates collected from January to June 2010 from the NHLS Central TB referral laboratory in Braamfontein, Johannesburg, representing a diversity of strains from South Africa, were included. The isolates were submitted for genotyping, pncA sequencing and analysis to the Centre for Tuberculosis in South Africa and the Public Health Research Institute Tuberculosis Center at Rutgers University in the United States. Clustering rates, Hunter-Gaston Discriminatory Indexes (HGI) and Wallace coefficients were compared between the methods. RESULTS: Overall clustering rates were high by both IS6110-RFLP (52.8%) and MIRU-VNTR (45.8%), indicative of on-going transmission. Both 24-loci MIRU-VNTR and IS6110-RFLP had similar HGI (0.972 and 0.973, respectively), with close numbers of unique profiles (87 vs. 70), clustered isolates (129 vs. 146), and cluster sizes (2 to 26 vs. 2 to 25 isolates). Spoligotyping alone was the least discriminatory (80.1% clustering, HGI 0.903), with 28 unique types. However, the discriminatory power of spoligotyping was improved when combined with pncA sequencing using the SpoNC approach (61.8% clustering, HGI 0.958). A high proportion of MDR-TB isolates had mutations in pncA (68%, n = 145), and pncA mutations were significantly associated with clustering (p = 0.007 and p = 0.0013 by 24-loci MIRU-VNTR and IS6110-RFLP, respectively), suggesting high rates of resistance to pyrazinamide among all MDR-TB cases and particularly among clustered cases. CONCLUSION: We conclude that SpoNC provides good discrimination for MDR-TB surveillance and early identification of outbreaks in South Africa, with 24-loci MIRU-VNTR applied for pncA wild-type strains as needed. Public Library of Science 2016-01-11 /pmc/articles/PMC4713439/ /pubmed/26752297 http://dx.doi.org/10.1371/journal.pone.0146106 Text en © 2016 Said et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Said, Halima M.
Kushner, Nicole
Omar, Shaheed V.
Dreyer, Andries W.
Koornhof, Hendrik
Erasmus, Linda
Gardee, Yasmin
Rukasha, Ivy
Shashkina, Elena
Beylis, Natalie
Kaplan, Gilla
Fallows, Dorothy
Ismail, Nazir A.
A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title_full A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title_fullStr A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title_full_unstemmed A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title_short A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
title_sort novel molecular strategy for surveillance of multidrug resistant tuberculosis in high burden settings
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713439/
https://www.ncbi.nlm.nih.gov/pubmed/26752297
http://dx.doi.org/10.1371/journal.pone.0146106
work_keys_str_mv AT saidhalimam anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT kushnernicole anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT omarshaheedv anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT dreyerandriesw anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT koornhofhendrik anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT erasmuslinda anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT gardeeyasmin anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT rukashaivy anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT shashkinaelena anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT beylisnatalie anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT kaplangilla anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT fallowsdorothy anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT ismailnazira anovelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT saidhalimam novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT kushnernicole novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT omarshaheedv novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT dreyerandriesw novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT koornhofhendrik novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT erasmuslinda novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT gardeeyasmin novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT rukashaivy novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT shashkinaelena novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT beylisnatalie novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT kaplangilla novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT fallowsdorothy novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings
AT ismailnazira novelmolecularstrategyforsurveillanceofmultidrugresistanttuberculosisinhighburdensettings